BRAND NAME | COMPOSITION | PRESENTATION | DOSAGE FORM | LOCATION CERTIFICATION | DOSSIER STATUS |
ANTIBIOTICS (ORAL SOLUTION) | |||||
SEQUENRO 10% | ENROFLOXACIN 10% ORAL SOLUTION | 500 ml | SOLUTION | WHO-GMP | √ |
1 lit | SOLUTION | WHO-GMP | √ | ||
SELVO ORAL | LEVOFLOXACIN 10% ORAL SOLUTION | 500 ML, 1 LIT | SOLUTION | WHO-GMP | √ |
FEED SUPPLEMENT | |||||
ENERZYME | EACH KG CONTAIN
CELLULASE …….100000000 IU XYLANASE……300000 IU BETA GLUCOSIDASE ……….10000 IU ARABINASE………….7000 IU PECTNASE ………….30000 IU PHYTASE……………..1500000 IU P ROTEASE…………….50000 IU LIPASE……………….28000 IU ALPHA GALACTOSIDASE ……10000 IU |
25 kg | POWDER | GMP | |
ENERZYME PRO | COMPOSITION ACID & ALKALI PROTEASE CONSORTIUM…….700000 UNIT/G MANNANASE ….600 UNIT/G PROTEIN ENHANCING FACTOR (PEF)…20 %. | 25 kg | POWDER | GMP | |
Alvitox | specially treated Hydrated Sodium Calcium Aluminosilicate (HSCAS) and buffered organic acids | 25 kg | POWDER | GMP | |
Alvitox Bio | specially treated Hydrated Sodium Calcium Aluminosilicate (HSCAS) ,Mannan Oligo Saccharide (MOS), Buffered Organic Acids, Activated Charcoal & Gentian Violet. | 25 kg | POWDER | GMP | |
Alvi – PH* | Phosphoric Acid (85%) …………………………….. 100 g.
Formic Acid (85%)…………………………………………….100 g. Citric Acid ………………………………………………… 10 g. Malic Acid ……………………………………………….. 5 g. Fumaric Acid ……………………………………………. 5 g. Lactic Acid ………………………………………………. 2 g. Propionic acid/ Ca- propionate……………………………….. 5g Yucca extracts (rich in saponins)…………………………….. 30 g |
25 Kg | POWDER | GMP | |
DISINFECTANT | |||||
SEQUSWEEP | GLUTARALDEHYDE (50%) :7.1% W/V, ALKYL BENZYL DIMETHYL AMMONIUM CHLORIDE: 25.7% W/V, ETHOXYLATE (12) NONYL PHENOL: 7.5% W/V | 1 LIT | SOLUTION | GMP | |
5 LIT | SOLUTION | GMP |